Christopher P. Cochran - Net Worth and Insider Trading
Christopher P. Cochran Net Worth
The estimated net worth of Christopher P. Cochran is at least $10,645 dollars as of 2024-05-28. Christopher P. Cochran is the Director of Coeptis Therapeutics Holdings Inc and owns about 37,000 shares of Coeptis Therapeutics Holdings Inc (COEP) stock worth over $10,645. Details can be seen in Christopher P. Cochran's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher P. Cochran has not made any transactions after 2024-01-05 and currently still holds the listed stock(s).
Transaction Summary of Christopher P. Cochran
Christopher P. Cochran Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P. Cochran owns 1 companies in total, including Coeptis Therapeutics Holdings Inc (COEP) .
Click here to see the complete history of Christopher P. Cochran’s form 4 insider trades.
Insider Ownership Summary of Christopher P. Cochran
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-05 | director |
Christopher P. Cochran Latest Holdings Summary
Christopher P. Cochran currently owns a total of 1 stock. Christopher P. Cochran owns 37,000 shares of Coeptis Therapeutics Holdings Inc (COEP) as of January 5, 2024, with a value of $10,645.
Latest Holdings of Christopher P. Cochran
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-05 | 37,000 | 0.29 | 10,645 |
Holding Weightings of Christopher P. Cochran
Christopher P. Cochran Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P. Cochran has made a total of 1 transactions in Coeptis Therapeutics Holdings Inc (COEP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coeptis Therapeutics Holdings Inc is the acquisition of 7,000 shares on January 5, 2024, which cost Christopher P. Cochran around $5,390.
Insider Trading History of Christopher P. Cochran
- 1
Christopher P. Cochran Trading Performance
GuruFocus tracks the stock performance after each of Christopher P. Cochran's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P. Cochran is -53.28%. GuruFocus also compares Christopher P. Cochran's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P. Cochran within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher P. Cochran's insider trading performs compared to the benchmark.
Performance of Christopher P. Cochran
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.72 |  | | | | |
| Relative Return to S&P 500(%) | -27.95 | | | | | |
Christopher P. Cochran Ownership Network
Christopher P. Cochran Owned Company Details
What does Coeptis Therapeutics Holdings Inc do?
Who are the key executives at Coeptis Therapeutics Holdings Inc?
Christopher P. Cochran is the director of Coeptis Therapeutics Holdings Inc. Other key executives at Coeptis Therapeutics Holdings Inc include director & 10 percent owner & CEO and President David Mehalick , director & VP of Operations Daniel Alexander Yerace , and director & 10 percent owner & Chief Financial Officer Chris Calise .
Coeptis Therapeutics Holdings Inc (COEP) Insider Trades Summary
Over the past 18 months, Christopher P. Cochran made 1 insider transaction in Coeptis Therapeutics Holdings Inc (COEP) with a net purchase of 7,000. Other recent insider transactions involving Coeptis Therapeutics Holdings Inc (COEP) include a net purchase of 44,244 shares made by Gene Salkind , a net purchase of 25,054 shares made by David Mehalick , and a net purchase of 11,582 shares made by Chris Calise .
In summary, during the past 3 months, insiders sold 0 shares of Coeptis Therapeutics Holdings Inc (COEP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Coeptis Therapeutics Holdings Inc (COEP) were sold and 105,996 shares were bought by its insiders, resulting in a net purchase of 105,996 shares.
Coeptis Therapeutics Holdings Inc (COEP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Coeptis Therapeutics Holdings Inc Insider Transactions
Christopher P. Cochran Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P. Cochran. You might contact Christopher P. Cochran via mailing address: 105 Bradford Rd., Suite 420, Wexford Pa 15090.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
